Skip to content

NeoGenomics NEO Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Natera, Inc. logo
Natera, Inc.NTRA
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
Agilent Technologies logo
Agilent TechnologiesA
CareDx logo
CareDxCDNA
TEC
Bio-TechneTECH
Veracyte logo
VeracyteVCYT

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B+86.5%
Enterprise value$1.6B+159%
P/S2.3×+0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's accrued manufacturing costs?
NeoGenomics (NEO) reported accrued manufacturing costs of $40.58M in Q1 2026.
How has NeoGenomics's accrued manufacturing costs changed year-over-year?
NeoGenomics's accrued manufacturing costs increased by 2.8% year-over-year, from $39.49M to $40.58M.
What is the long-term trend for NeoGenomics's accrued manufacturing costs?
Over 5 years (2020 to 2025), NeoGenomics's accrued manufacturing costs has grown at a 14.0% compound annual growth rate (CAGR), from $24.73M to $47.58M.